Zacks Investment Research downgraded shares of REGADO BIOSCI (RGDO) from OUTPERFORM to NEUTRAL on October 01, 2014, with a target price of $1.30.
Regado Biosciences, Inc. is a biopharmaceutical company. It focuses on the discovery and development of antithrombotic drug systems for acute and sub-acute cardiovascular and other indications. Regado Biosciences, Inc. is headquartered in Basking Ridge, New Jersey.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
To get a free copy of the research report on REGADO BIOSCI (RGDO),
click here.
For more information about research offerings from Zacks Investment Research, visit
Zacks.com .
Be the first to comment